Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Chronic Fatigue Syndrome/ME: A real disease? Gavin Spickett Consultant Clinical Immunologist Royal Victoria Infirmary Chronic Fatigue Syndrome (ME) What is it? Is it a real illness? What are the symptoms? How is it treated? What is the prognosis? How will affect patients? What is chronic fatigue? Fatigue and tiredness are not the same! Because there is little to see and no specific findings on examination or routine tests it is easy to dismiss it as psychologically based Good fun for cartoonists – but not much fun for patients What is chronic fatigue? CFS/ME affects all social classes and all races but healthcare behaviour when ill biases social analysis limited to clinic referral! What is CFS(ME)? Classified by WHO in ICD-10 as a neurological disorder G93.3 Medical unexplained Physiologically distinct from depression Identifiable immunological, neurological, endocrine abnormalities that are consistent It is not a somatisation disorder Somatisation may present as CFS and forms part of the differential diagnosis Medically unexplained does not equal somatisation!! What is CFS/ME? Severe debilitating fatigue causing interference with normal functions. No evidence for other medical or psychiatric problems. Typical history No pointers on examination to alternative diagnoses. Blood tests are normal What is fatigue Fatigue is not the same as tiredness and is not relieved by sleep or rest. It is common to a broad range of chronic medical illnesses. Our understanding and recognition of the importance of fatigue in chronic illness is improving. Fatigue Fatigue Chronic infection Connective tissue disease Autoimmune disease Sleep disturbance Organic brain disease EBV Toxoplasma HCV, HIV (AIDS) Brucella Lupus Rheumatoid arthritis Polymyositis Coeliac disease Thyroid disease Addison’s disease PBC Sleep apnoea Sleep deprivation narcolepsy Alzheimer’s MS Parkinson’s Disease Primary psychiatric Also consider other organ-based disease (lung (COPD), heart, liver, kidney, bowel), malignancy and chemotherapy/radiotherapy, brain injury, PTSD, diabetes History of CFS/ME Not a new illness! Almost certain medical descriptions from 1750 onwards Neurasthenia described in mid 19th Century 1936 – Winsconsin Convent disease 1937-1939 ‘abortive polio’ in Swiss Towns and Army 1938 – polio-like illness in Los Angeles History of CFS/ME Epidemics of polio-like illnesses worldwide Iceland – Akureyri disease Adelaide – 800 people ill from 1949-1951 Other affected Countries included USA. Denmark, South Africa Royal Free Disease 1955 (benign myalgic encephalomyelitis Lake Tahoe outbreak 1980’s (“Raggedy Anne syndrome”) – originally thought to be ‘chronic EBV’ – subsequently refuted George Miller Beard 1839-1883 Graduated from Yale 1862 Served as assistant surgeon US Navy in American Civil War Champion of ‘electrotherapy’ First described Neurasthenia Neurasthenia A condition characterised by Fatigue Anxiety & Depression Headache Impotence Neuralgia Exhaustion of the nervous system’s energy resources Associated with ‘the stress of urbanisation’ Neurasthenia Concept remained popular into early 20th Century Other synonyms include Effort Syndrome Da Costa’s syndrome Thought to be behavioural Now consigned under ICD-10 to classification F48 – Other Neurotic Disorders! Royal Free Disease 1955 outbreak at RFH in London affecting staff Associated with inflammation of brain and spinal cord Neuroimmune pathogenesis suggested Epidemic vs Sporadic Disease Epidemic form described by Psychiatrists McEvedy and Beard as ‘mass hysteria’ in 1970 Findings refuted subsequently (poor descriptions of patients) Symposium 1978 at RSM concluded that epidemic myalgic encephalomyelitis was a distinct disease entity Epidemic form not seen now Last epidemic at Lake Tahoe mid-1980s Unclear why Strongly suggestive of infectious agent No agent ever identified for main epidemics Epidemiology Prevalence of 0.2-0.4% Average GP practice of 10,000 will have up to 40 patients Estimated annual prevalence 4000 cases/million population Recognition of CFS/ME Gradual acceptance of reality of the illness at official levels 1996 - Kenneth Calman (CMO) commissioned report form Royal Colleges 2002 – Report by Liam Donaldson (CMO) Royal Colleges of Physicians, Psychiatrists and General Practitioners. Chronic fatigue syndrome: Report of a joint working group or the Royal Colleges of Physicians, Psychiatrists and general Practitioners. London, 1996 CFS/ME Working Group. A report of the CFS/ME working group: report to the Chief Medical Officer of an independent working group. DH, 2002 2005-6 DH funded specialist services for CFS/ME in England (but no funded services in Scotland or N. Ireland) Is it a real illness? Medically unexplained = patient is mad or bad! Almost all patients are devastated by their illness and suffer depression as a result. Most will suffer severe hardship with loss of income, job, loss of hobbies, marital difficulties. Difficult to conceive that the majority of patients would wish to continue in this state CFS/ME as a Psychological Disease? Assumed (by Psychiatrists and Psychologists) to be: Variant of depression/anxiety Somatisation Factitious illness Lack of acceptance in some quarters of medical profession that this is an illness with real physiological abnormalities distinct from those seen secondary to depression Many GPs still treat fatigued patients with antidepressants despite the lack of evidence for depression or benefit from the drugs. CFS/ME as a Psychological Disease? 1997: Elaine Showalter described CFS as a “hysterical narrative” – a modern manifestation of hysteria, a self-perpetuating “cultural symptom of anxiety and stress” (Hystories: hysterical epidemics and modern culture) Is it a real illness? Scientific evidence now points to underlying physiological abnormalities. Psychiatric symptoms are secondary. Anger Frustration Reactive depression and anxiety Aetiology Uncertain Two presentations: Acute, usually following infective sounding illness Gradual, no obvious predisposing factors Unclear whether these are the same or separate illnesses Infectious Agents Through 1960s disease attributed to chronic EBV (USA rules for benefits suggested patients must have high antibodies to EBV!!) ; other Herpes viruses (CMV) 1960s-1970s attributed to chronic Brucellosis 1990s suggestion of association with retrovirus HTLV-II (later refuted) 1990s association with Coxsackieviruses popular (based on poor quality test) Infectious Agents 2009 – report from USA associating CFS/ME with murine endogenous retrovirus XMRV 2010 – 2011: findings not repeated. Original Lab confirms contamination Aetiology Genetic predisposition Chronic fatigue syndrome Intercurrent infection Psychosocial background Aetiology Evidence supporting an organic basis against a psychological basis Neuronal abnormalities Neurocognitive disorder Autonomic dysfunction Functional MRI scanning muscles Genetic predisposition (multiple genes, immune system, brain); runs in families Endocrine abnormalities (adrenocortical axis, sex hormones) Genetic predisposition Psychosocial background Triggering event (infection) Dysfunctional immunological response Chronic cytokine abnormalities Endocrine disturbance (adrenocortical axis) Autonomic dysfunction POTS, postural hypotension, abnormal muscle and skin blood flow Mitochondrial abnormality? Aetiology Genetics Evidence for specific patterns of gene activation/repression in CFS Brain – neuronal function Immune system regulatory genes Apoptosis Cytokines Endocrine system Cardiovascular system Mitochondrial function Likely to be polygenic Aetiology Infectious triggers Any infection Viral Bacterial Herpes viruses (EBV, CMV, HHV6, HHV7 Ross River virus Borna Disease Parvovirus Severe pneumonia Parasitic Aetiology Psychosocial background Increase in major life events in year preceding Divorce Bereavement Unemployment High proportion of patients have history of abuse (sexual, physical, mental) Autonomic disorder Evidence that dysfunction of autonomic system correlates with level of fatigue Associated with Heart rate and blood pressure abnormalities Disordered blood flow in skin (temperature dysregulation, sweating) Muscle pain (failure to clear lactate on exercise) Bowel symptoms Breathing difficulty (increased awareness, subjective shortness of breath) Aetiology – other factors Immunological abnormalities Cytokine disorder (excess IL-6) Altered Th1-Th2 balance Reduced natural killer cells Disordered gene activation (over/under) Endocrine abnormalities Hypothalamic-Pituitary axis Low cortisol Enhanced feedback sensitivity Reduced oestrogen and testosterone Aetiology – other factors Oxidative stress Mitochondrial disorder Abnormalities of genes involved in control of oxidative stress Unproven Mitochondrial myopathies form part of differential diagnosis Toxins Organophosphate insecticides - unproven PET Scan Abnormalities Evidence on functional brain scanning for reproducible abnormalities Abnormalities are different from those seen in depression! Evidence of neurocognitive disorder Short-term memory Word-finding difficulty Aetiology There is no evidence that CFS(ME) is caused by: Amalgam fillings Chronic candida overgrowth syndrome Environmental intolerance Food allergies (common and occur by chance together with CFS) Undiagnosed thyroid disorder (NHS tests ‘no use’) What are the symptoms? Symptoms are very stereotyped However symptoms are not unique to CFS/ME. Typical symptoms Flu-like malaise Muscle, joint pain, cramp Intolerances Worse after activity No joint swelling Tenderness at FM points Disturbed body temperature Inappropriate to environment Inappropriate sweating Noise Light Touch Smell Medications Dizziness Pre-syncope Blackouts Postural hypotension Typical symptoms Palpitations Anxiety Postural Bloating Diarrhoea/constipation Food intolerances (NOT allergy!!) Headache/migraine Tinnitus, vertigo Pins & needles Neurocognitive problems Irritable bowel (100%!) Unrefreshing sleep Poor concentration Poor short term memory Word-finding difficulty Sleep disturbance Worse with over-exertion Sore throat/swollen glands Presentation Diagnosis of CFS Diagnosis is primarily one of exclusion Diagnosis is therefore difficult and dependent on the skill of the clinician Fatigue is not a unique symptom! Fatigue is the final common pathway of many discrete diseases Fatigue has a complex aetiology and involves multiple organ systems Fatigue is NOT the same as tiredness Chronic Fatigue Syndrome Exclusions to diagnosis of CFS (Fukada) Organ failure (emphysema, cardiac, liver, kidney) Chronic infections Rheumatic/chronic inflammatory conditions Major neurological disease (MS, Myasthenia) Systemic treatment for neoplasms Untreated endocrine disorders Primary sleep disorders (narcolepsy, sleep apnoea) Obesity (BMI > 40) Alcohol/substance abuse Reversible causes of fatigue (operations, medication) Psychiatric disorders (depression, bipolar disorder, psychosis, eating disorders) Chronic Fatigue Syndromes Irritable bowel syndrome CFS (post-viral fatigue) Fibromyalgia POTS Over-training syndrome Chronic Fatigue Syndrome Referrals from primary care Strict referral criteria Pre-referral screening bloods Duration of fatigue No identifiable cause Need to be up-to-date Screen out many treatable causes so that inappropriate therapy is not offered N.B. – there is no single diagnostic test to confirm or refute the diagnosis Medical Screening Referral from primary care (6 minute consultations); pathway with pre-screening Role of experienced physician/paediatrician Identification of non CFS/ME conditions 49% of referred patients do NOT have CFS/ME Identification of important CFS-related conditions for which specific drug treatment may be required Pain POTS Sleep disturbance Secondary depression Outcome of Clinical Assessment 2007 – 49% of patients referred from primary care do NOT have CFS/ME 2010 – Same figure, also replicated by CFS Service at St. Bartholomews Hospital, London Clinicians getting better at identifying other causes Earlier referral – other diseases may not yet have fully declared themselves Refer on to therapy teams for management where CFS/ME confirmed (CBT therapist, OT, Physio, Nurse) Clinical Services Set up and funded by DH after CMOs report Only for England and Wales No services in Scotland £8.5m investment Requirement on PCTs to fund services (!) Regional Networks and Area Teams Varying structures, pathways and models of care! Varying effectiveness Clinical Services NICE Guidelines introduced in August 2007 Recommendations for referral and management Recommendations regarding appropriate and inappropriate treatments Although these are ‘Guidelines’, clinicians are ‘expected’ to use them and PCTs are ‘expected’ to fund the services! Recognised that “CFS/ME should be considered as disabling a condition as multiple sclerosis or rheumatoid arthritis” NICE Guidelines Judicial Review granted in June 2008 2 patients challenged the Guidelines on the basis that NICE recommended only treatments (GET and CBT) that in their view would be harmful to their health Witness statements for the appellants attacked both the process, including selection of experts, and the individuals involved in the process directly Irrationality of decision to recommend CBT & GET Pre-determination (i.e. selection bias in evidence and members of panel) NICE Guidelines Judicial Review under Justice Simon reported on 13th March 2009 ([2009] EWHC 452 (Admin)) Dismissed the irrationality argument Concluded on the issue of pre-determination that appellants allegations against the individuals were unfounded and biased by the use highly selective quotations taken out of context Concluded that the selection process by NICE was appropriate Concluded that the appellants could not be held to represent the CFS/ME community Drew attention to the damage that the personal attacks on individual members would have on recruitment to NICE panels and on scientific enquiry Therapy Interventions Therapy interventions based around models used for chronic pain team (biopsychosocial model). Time limited. Combination of approaches from MDT Activity- based Pacing, graded exercise, avoidance of ‘boom-and-bust’ Sleep hygiene General advice (diet, deconditioning, benefits, employment etc) Lifestyle management CBT; mindfulness; Lightning therapy Physiotherapy & OT support Individual and Group based Use of drugs only for symptom management Therapy Interventions No curative therapies (orthodox!) Small Norwegian study reported significnat improvement in small number of patients receiving rituximab (an anti-cancer drug) Alternative sector offers many unproven therapies. This study needs to be repeated in blinded fashion with larger study group MRC Study did not show benefit from Pacing What are the outcomes? There is no curative therapy. NICE approved therapies are supportive not curative Chance of spontaneous recovery is dependent on duration of illness. Early signs of improvement are a positive prognostic indicator. Lack of improvement by 2 years is a poor prognostic indicator Outcomes CDC Review of published date identified: 8-63% showed evidence of recovery (mean 43%) 5-10% only showed full recovery Local surveys (Therapy Teams & ME Northeast) 10% +/- 2% not improved/worse after therapeutic intervention Current scoring systems do not reflect benefit Increased anxiety related to developing understanding of chronic disabling nature of illness Fatigue may not change Improvement from increased activity? Mortality Retrospective study 2006 using memorial list of CFS Support Group (difficulties in accessing accurate data) Increased likelihood of death from heart failure, suicide and cancer NB – separate studies have shown sub-population with progressive heart muscle disease Ages of death younger than general population Larger 14 year retrospective study in 2006 All-cause mortality and suicide rates not significantly different from standardised mortality rates Assisted Suicide Gilderdale case 2009 Kay Gilderdale found not guilty of murder for assisting the suicide of her daughter who was said to have ME for 17 years Assisted daughter to administer morphine overdose and air via Hickman line Judge Richard Brown had questioned the decision by the CPS to proceed with charges Economic Cost of CFS/ME UK 1998 Cost per patient £5,095 (20% attributable to medical costs, remainder to benefits, lost productivity and tax revenue) Estimated cost to community of £1 billion USA 2004 Cost of $20,000 per patient with CFS in lost productivity Total lost productivity $9.1 billion How does CFS/ME affect patients? Major issues are: Neurocognitive problems Delayed response to activity (boom-and-bust) Many patients will become: Agarophobic/social phobic (negative peer feedback (especially teenagers) Trapped in negative feedback loop Secondary depression/anxiety Bed-bound = disaster! Problems for patients with CFS/ME Lack of recognition of the illness Lack of empathy from healthcare professionals Discrimination Medical Employers/education Friends and family Benefits Insurance Problems for patients with CFS/ME Neurocognitive difficulties make work difficult/impossible and make it hard for patients to fill in forms. Some patients are unsafe left unsupervised (fire risk, flood risk, falls) Benefit forms do not reflect the type of disability that the patients’ suffer e.g. delayed deterioration: they can walk today but if they do they won’t be able to tomorrow. Benefits Pensions Difficulties in determining long-term outcomes Acceptance of the illness by pension providers Incapacity Benefit/Employment Support Allowance Disability Living Allowance and Attendance Allowance Permanent Health Insurance Benefits Many occupational health, benefits and pensions medical specialists, psychologists and psychiatrists believe that seeking benefits leads to persistence of symptoms and exaggeration of disability This is a gross misperception Most patients are devastated by their illness and would give anything they have to get better (hence expenditure on alternative therapies) Most have suffered substantial financial and physical loss Most have no plausible reason not to get better Most become depressed because of their illness Many have given up because of the negativity of the medical profession Fights over benefits, pensions and insurance are difficult and actually prevent the patients getting better Benefits 2006 Report by UK Parliamentary Group on Scientific Research into Myalgic Encephalomyelitis noted that: “CFS/ME is defined as a psychosocial illness by DWP and Medical Insurance Companies. Therefore claimants are not entitled to the higher level of benefits payments. We recognise that if CFS/ME remains as one illness and/or both remain defined as psychosocial then it would be in the financial interest of both the DWP and the medical insurance companies.” Benefits Advisers to DWP have also had consultancy roles in medical insurance companies Perpetuates misbeliefs about CFS/ME Not in keeping with CMO’s report, best current research or with the NICE Guidelines! Viewed as conflict of interest and not in patients’ interests? Contributes to adversarial approach to benefits/insurance claims Causes immense difficulty for patients Appeals and Tribunals CFS/ME patients rarely get benefits on first application This is despite the fact that the NICE Guidelines says that it is a disabling condition as severe as MS and Rheumatoid Arthritis! Appealing decision is time-consuming and a struggle Many patients have difficulty accessing experienced benefits advisers to represent them Many CABs do not understand CFS/ME and therefore do not represent clients adequately Conclusions CFS/ME is a chronic disabling disease with a genetic background, triggered by infection and with a link to psychosocial stressors There is increasing evidence of very specific physiological abnormalities that deny that the illness is just a psychological illness There are still no curative treatments Patients have major problems with disbelief within medical and benefits/insurance/pensions systems Thank you for your attention